NCT00154713 Immunotherapy for Colorectal Cancers Using CEA-Pulsed Dendritic Cells and Subsequent IL-2 Treatment Status UNKNOWN Phase PHASE1/PHASE2
NCT00153998 Cetuximab in Neoadjuvant Treatment of Non-Resectable Colorectal Liver Metastases (CELIM) Status COMPLETED Phase PHASE2
NCT00152230 A Randomized Controlled Study of Postoperative Adjuvant Chemotherapy of Uracil- Tegafur (UFT) Compared With Surgery Alone (NSAS-CC) Status COMPLETED Phase PHASE3
NCT00149396 Safety & Efficacy of NV1020 in Colorectal Cancer Metastatic to the Liver Status COMPLETED Phase PHASE1/PHASE2
NCT00147134 A Trial to Evaluate Laparoscopic Versus Open Surgery for Colorectal Cancer Status COMPLETED Phase PHASE3
NCT00145860 Do Patients With Colorectal Cancer Understand That Their Family is at Risk? Status TERMINATED Phase N/A
NCT00145015 FishGastro Study: Fish Consumption and Gastro-Intestinal Health Status COMPLETED Phase NA
NCT00136227 Use and Decision-making About Colorectal Cancer Screening Among Hispanic Men and Women Status COMPLETED Phase NA
NCT00133913 Circulating Tumor Cells in Patients With Metastatic Colorectal Cancer Status UNKNOWN Phase N/A
NCT00132522 EMD 273066 in Patients With Recurrent EpCAM Positive Ovarian, Prostate, Colorectal or Non-small Cell Lung Cancers When First Given Cyclophosphamide Status COMPLETED Phase PHASE1
NCT00131586 Cisplatin, Carboplatin, and Oxaliplatin Interactions With Plasma Proteins Status TERMINATED Phase N/A
NCT00129870 CONCEPT: Comparison of Oxaliplatin vs Conventional Methods With Calcium/Magnesium in First-Line Metastatic Colorectal Cancer Status TERMINATED Phase PHASE4
NCT00128622 Denileukin Diftitox Followed by Vaccine Therapy in Treating Patients With Metastatic Cancer Status COMPLETED Phase PHASE1
NCT00126451 A Clinical Trial of Oral Suberoylanilide Hydroxamic Acid (SAHA) in Patients With Relapsed or Refractory Breast, Colorectal and Non-Small Cell Lung Cancer (0683-011)(TERMINATED) Status TERMINATED Phase PHASE2
NCT00126256 Trial Comparing Two Strategies of Chemotherapy for Metastatic Colorectal Cancer Status COMPLETED Phase PHASE3
NCT00125034 Oxaliplatin and Cetuximab in First-line Treatment of Metastatic Colorectal Cancer (mCRC) Status COMPLETED Phase PHASE2
NCT00123851 Tarceva, Capecitabine and Oxaliplatin for Metastatic Colorectal Cancer Status COMPLETED Phase PHASE2